HTAi IS A GLOBAL HEALTH TECHNOLOGY ASSESSMENT (HTA) SOCIETY

A Global Society Championing Equitable, Responsive, And Cutting-Edge
Health Technology Assessment (HTA)

HTAi IS THE WORLD'S ONLY GLOBAL HEALTH TECHNOLOGY ASSESSMENT (HTA) SOCIETY.

A Global Society Championing Equitable, Responsive, And Cutting-Edge Health Technology Assessment (HTA)

Founded in 2003 in Canmore, Alberta, Canada, HTAi is a vibrant and growing community of multidisciplinary advisors, academics, scientists, professionals, public & private organizations, students, patient and citizen members who are dedicated to better health for all people and the future of HTA worldwide.

Through our premier events, key networking opportunities, and member-driven HTA advocacy:

HTAi shapes, champions, innovates, bridges, and networks the future global HTA.

Founded in 2003 in Canmore, Alberta, Canada, HTAi is a vibrant and growing community of multidisciplinary advisors, academics, scientists, professionals, public & private organizations, students, and citizen members who are dedicated to better health for all people and the future
of HTA worldwide.

Through our premier events, key networking opportunities,
and member-driven HTA advocacy:

HTAi shapes, champions, innovates, bridges, and networks the future global HTA.

What is Health Technology Assessment (HTA)?

Informing decision-making to promote an equitable, efficient, and high-quality health system,
HTA is a multidisciplinary process that uses explicit methods to determine the value
of a health technology at different points in its lifecycle.
A health technology is an intervention developed to prevent, diagnose, or treat medical
conditions; promote health; provide rehabilitation; or organize healthcare delivery,

The intervention can be a test, device, medicine, vaccine, procedure, program, or system.

What is Health Technology Assessment (HTA)?

Informing decision-making to promote an equitable, efficient, and high-quality health system, HTA is a multidisciplinary process that uses explicit methods to determine the value of a health technology at different points in its lifecycle.
A health technology is an intervention developed to prevent, diagnose, or treat medical conditions; promote health; provide rehabilitation; or organize healthcare delivery,

The intervention can be a test, device, medicine, vaccine, procedure, program, or system.

HTAi’s MEMBERS ARE THE VANGUARD OF GLOBAL HTA.

HTAi is governed by an elected International Board of Directors, supported by an Executive Committee, several Advisory Committees, Working Groups, and a Secretariat. We drive global HTA advocacy through our three Policy Forums, our Annual Meeting, the HTAi Interest Groups, and support and recognize HTA innovation through the David Banta Award and the IJTAHC Egon Jonsson Award.

The Board of Directors appoints and delegates some of its work to committees, sub committees and working groups.

HTAi’s MEMBERS ARE THE VANGUARD OF GLOBAL HTA.

HTAi is governed by an elected International Board of Directors, supported by an Executive Committee, several Advisory Committees, Working Groups, and a Secretariat. We drive global HTA advocacy through our three Policy Forums, our Annual Meeting, the HTAi Interest Groups, and support and recognize HTA innovation through the David Banta Award and the IJTAHC Egon Jonsson Award.

Board of Directors

WIJA OORTWIJN

THE NETHERLANDS 2021-23

RABIA KAHVECI

UKRAINE 2021-23

JO CAROL HIATT

USA 2021-24​

AMERICO CICCHETTI

ITALY 2021-24

IÑAKI GUTIERREZ-IBARLUZEA

SPAIN 2021-23

VANIA CANUTO

BRAZIL 2020-23

WIM GOETTSCH

NETHERLANDS 2022-25

DIMITRA LINGRI

GREECE 2022-25

LI YING (GRACE) HUANG

TAIWAN 2020-23

DEBJANI (JANI) MUELLER

SOUTH AFRICA 2022-25

MARCO MARCHETTI

ITALY 2022-2025

FRANZ WAIBEL

SWITZERLAND 2020-23

Board of Directors

The Netherlands 2021-23

Ukraine 2021-23

USA 2021-24​

ITALY 2021-24

BRAZIL 2020-23

NETHERLANDS 2019-22

GREECE 2022-25

TAIWAN 2020-23

SOUTH AFRICA 2019-22

ITALY 2019-25

SWITZERLAND 2020-23

OBSERVERS

TRACY MERLIN

INAHTA AUSTRALIA

WENDY BABIDGE

IJTAHC EDITOR-IN-CHIEF AUSTRALIA

POLICY FORUM CHAIRS

DAN OLLENDORF

HTAi GLOBAL POLICY FORUM CHAIR (2020-2022) UNITED STATES

MANUEL ANTONIO ESPINOSA

LATIN AMERICA POLICY FORUM CHAIR (2022-2024) CHILE

GUY MADDERN

HTAi ASIA POLICY FORUM CHAIR (2022-2024) AUSTRALIA

OBSERVERS

INAHTA AUSTRALIA

IJTAHC EDITOR-IN-CHIEF AUSTRALIA

POLICY FORUM CHAIRS

HTAi GLOBAL POLICY FORUM CHAIR (2020-2022) UNITED STATES

LATIN AMERICA POLICY FORUM CHAIR (2022-2024) CHILE

HTAi ASIA POLICY FORUM CHAIR (2022-2024) AUSTRALIA

HTAi SECRETARIAT

ROB ABBOTT

EXECUTIVE DIRECTOR

ALICIA POWERS

MANAGER, POLICY FORUMS & EVENTS

MELISSA DONECZ

HTAi ACCOUNTING MANAGER

DENISE JARRETT

MANAGER, ANNUAL MEETINGS

ANTONIO MIGLIORE

MANAGER, SCIENTIFIC INITIATIVES

MARLENE HANKE

MANAGER, CORPORATE SERVICES

NICOLA VICARI

COORDINAR, SCIENTIFIC INITIATIVES

AMREN THAKUR

SENIOR COORDINATOR, SCIENTIFIC INITIATIVES

TATIANA HAGERTY

SENIOR COORDINATOR, GOVERNANCE & EXECUTIVE PROJECTS

NAOMI SUWINSKI

LEAD, CORPORATE COMMUNICATIONS

HANA PRICE

SENIOR COORDINATOR, EVENTS

BREANNE DICKHOUT

PROJECT COORDINATOR, EVENTS

GERARDO CEA

COORDINATOR, TECHNOLOGY

HTAi SECRETARIAT

EXECUTIVE DIRECTOR

MANAGER, POLICY FORUMS & EVENTS

MANAGER, FINANCE

MANAGER, ANNUAL MEETINGS

MANAGER, CORPORATE SERVICES

MANAGER, SCIENTIFIC INITIATIVES

COORDINATOR, SCIENTIFIC INITIATIVES

COMMITTEE LIAISON, ANNUAL MEETINGS

SENIOR COORDINATOR, GOVERNANCE & EXECUTIVE PROJECTS

LEAD, CORPORATE COMMUNICATIONS

SENIOR COORDINATOR, EVENTS

PROJECT COORDINATOR, EVENTS

COORDINATOR, TECHNOLOGY

HTAi COMMITTEES AND WORKING GROUPS

CHAIR:

  • Wija Oortwijn, President (The Netherlands)

MEMBERS:

  • Rabia Kahveci, Vice-President (Ukraine)
  • Americo Cicchetti, Treasurer (Italy)
  • Jo Carol Hiatt, Secretary (USA)

HTAi SECRETARIAT

  • Rob Abbott, HTAi Executive Director (Canada)
  • Tatiana Hagerty, Senior Coordinator, Governance and Executive Projects (Canada)

Terms of Reference

CHAIR:

  • Americo Cicchetti, Treasurer (Italy)

MEMBERS:

  • Marco Marchetti (Italy)
  • Franz Waibel (Switzerland)
  • Jo Carol Hiatt  (USA)
  • Wim Goettsch (The Netherlands)

HTAi SECRETARIAT

  • Rob Abbott, HTAi Executive Director (Canada)
  • Melissa Donecz, HTAi Accounting Manager (Canada)

Terms of Reference 

 

CHAIR:

  • Iñaki Gutierrez-Ibarluzea (Spain)

MEMBERS:

  • Dimitra Lingri (Greece)
  • Rabia Kahveci (Ukraine/Turkey)

HTAi SECRETARIAT SUPPORT

  • Tatiana Hagerty, Coordinator, Governance & Executive Projects (Canada)
  • Rob Abbott, Executive Director (Canada)

Terms of Reference

CHAIR:

  • Franz Waibel (Switzerland)

MEMBERS:

  • Marco Marchetti (Italy)
  • Jani Mueller (South Africa)
  • Neil Bertelsen (Germany)
  • VACANT
  • Dimitra Lingri  (Greece)
  • Parashar Patel (United States) 
  • Anke-Peggy Holtorf (Switzerland)
  • Jeanette Kusel (United Kingdom)

HTAi SECRETARIAT SUPPORT:

  • Rob Abbott, HTAi Executive Director (Canada)

Terms of Reference

CHAIR:

  • Jani Mueller (South Africa)

MEMBERS:

  • Alric Rüther (Germany)
  • Americo Cicchetti (Italy)
  • Andre Pichon-Riviere (Argentina)
  • Elena Petelos (The Netherlands)
  • Gert Jan van der Wilt  (The Netherlands)
  • Wija Oortwijn (The Netherlands)
  • Yingyao Chen (China)
  • Maoling Wei (China)
  • Sharmila Alina de Sousa (Brazil)
  • Franz Waibel (Switzerland) 

HTAi SECRETARIAT SUPPORT:

  • Rob Abbott, HTAi Executive Director (Canada)
  • Antonio Migliore, HTAi Manager, Scientific Initiatives (Canada)

Terms of Reference

CHAIR:

  • Wim Goettsch (The Netherlands)

MEMBERS:

  • Clifford Goodman (USA)
  • Iñaki Gutierrez-Ibarluzea (Spain)
  • Keng Ho Pwee (Singapore)
  • Alric Rüther (Germany)
  • Tracy Merlin (Australia)
  • Ana Perez Galan (Uruguay)

HTAi SECRETARIAT SUPPORT:

  • Rob Abbott, HTAi Executive Director (Canada)
  • Denise Jarrett, HTAi Manager, Annual Meeting (UK)
  • Amren Thakur, HTAi Senior Coordinator, Scientific Initiatives (Canada)

Terms of Reference

CHAIR:

  • Alicia Granados (Spain)

MEMBERS:

  • Clifford Goodman (United States)
  • Wija Oortwijn (The Netherlands)
  • Adrian Griffin (United Kingdom)
  • Christopher Henshall (United Kingdom)
  • Jasmine Pwu (Taiwan)
  • Andres Pichon-Riviere (Argentina)
  • Dan Ollendorf (United States)
  • Suzanne McGurn (Canada)
  • Guy Maddern (Australia)
  • Manuel Antonio Espinoza (Chile)

HTAi SECRETARIAT SUPPORT:

  • Rob Abbott, HTAi Executive Director (Canada)
  • Alicia Powers, HTAi Manager, Events (Canada)

Terms of Reference

CHAIR:

  • Rabia Kahveci (Ukraine)

MEMBERS:

  • Rosmin Esmail, Disinvestment and Early Awareness, Co-Chair (Canada)
  • Nora Ibargoyen Roteta, Disinvestment and Early Awareness, Co-Chair (Spain)
  • Denny John, Early Career Network, Co-Chair
  • Maoling Wei, Early Career Network,Co-Chair (China)
  • Pietro Refolo, Ethics, Co-chair (Italy)
  • Bart Bloemen, Ethics, Co-chair (The Netherlands)
  • Jani Mueller, HTA in Developing Countries, Chair (South Africa)
  • Richard Charter, Medical Devices, Chair (Switzerland)
  • Anastasia Chalkidou, Medical Devices, Co-Chair (UK)
  • Rossella Di Bidino, Hospital-Based HTA, Co-chair (Italy)
  • Iga Lipska, Hospital-Based HTA, Co-chair (Poland)
  • Maarten Postma, Public Health, Chair (The Netherlands)
  • Ingrid Harboe, Information Retrieval Group, Chair (Norway)
  • Amanda Hodgson, Information Retrieval Group, Co-Chair (Canada)
  • Ann Single, Patient and Citizen Involvement, Chair (Australia)
  • Valentina Strammielllo, Patient and Citizen Involvement, Co-Chair (Brussels)
  • VACANT – Patient and Citizen Involvement, Vice-Chair
  • Massoud Toussi, Regulatory Interactions & Conditional Coverage, Chair (France)
  • Elena Petelos, Real World Evidence and Artificial Intelligence, Co-Chair (The Netherlands)
  • Dimitra Lingri, Real World Evidence and Artificial Intelligence, Co-Chair (Greece)

HTAi SECRETARIAT SUPPORT:

  • Rob Abbott, HTAi Executive Director (Canada)
  • Antonio Migliore, HTAi Manager, Scientific Initiatives (Canada)

CHAIR:

  • Dan Ollendorf (USA)

SCIENTIFIC SECRETARY:

  • Rebecca Trowman (Australia)

MEMBERS:

  • James Ryan (United Kingdom)
  • Mohit Jain (united Kingdom) 
  • Nicole Mittmann (Canada)
  • Nick Crabb (United Kingdom)
  • Wim Goettsch (Netherlands)
  • Iñaki Gutierrez Ibarluzea (Spain)
  • Wija Oortwijn (Netherlands)
  • Alric Ruether (Germany)
  • Racho Strauven (Switzerland)

OBSERVERS:

  • Rob Abbott, HTAi Secretariat (Canada)
  • Ali Powers, Manager, Events (HTAi Secretariat, Canada)

Terms of Reference

CHAIR:

  • Guy Maddern (Australia)

SCIENTIFIC SECRETARY:

  • Linda Mundy (Australia)

MEMBERS:

  • Yan Ma (Viva) (Singapore)
  • Virginia Priest (New Zealand)
  • Parashar Patel (United States)
  • Sang-Soo(SS) Lee (Seoul, Korea)
  • Vanessa Xavier (Australia)
  • Izzuna Mudla Mohamed Ghazali (Kuala Lumpur, Malaysia)
  • Li-Ying Huang (Grace) (Taipei, Taiwan)
  • Julie Van Bavel (Australia)
  • Takashi Fakuda (Japan)
  • Hong Ju (Singapore)
  • Yingyao Chen (China)

HTAi SECRETARIAT:

  • Ali Powers, HTAi Manager, Events Canada)

Terms of Reference

CHAIR:

  • Manuel Antonio Espinoza

SCIENTIFIC SECRETARY:

  • Andres Pichon-Riviere (Scientific Secretary)
  • Gabriela Rodriguez (Administrative Contact)

MEMBERS:

  • Adriana Maria Robayo (Colombia)
  • Alicia Granados (Spain)
  • Dino Sepuilveda Viveros (Chile)
  • Fernanda Laranjeira (Brazil)
  • Hector Castro (United States)
  • Graciela Fernandez (Brazil)
  • Homero Monsanto (United States)
  • Vania Cristina Canuto Santos (Brazil)
  • William Dorling (United States)

HTAi SECRETARIAT:

  • Ali Powers, HTAi Manager, Events Canada)

Terms of Reference

CO-CHAIRS:

  • Prof. Dr. Gert van der Wilt
    Head of the HTA Unit, Radboud University Medical Centre
    Netherlands

  • Dr. W.G. Goettsch
    Special Advisor HTA, Zorginstituut Nederland and Utrecht University
    Netherlands

  • Ms. Ann Single
    Coordinator, Patient Voice Initiative | Chair, HTAi Patient and Citizen Involvement Interest Group
    Australia

MEMBERS:

  • Dr. Alric Rüther
    Head of International Affairs, Institute for Quality and Efficiency in Health Care (IQWiG) Germany
  • Dr. Izzuna Mudla Mohamed Ghazali
    Deputy Director, Ministry of Health Malaysia
  • Dr. Jon Campbell
    Sr Vice President, Health Economics, Institute for Clinical and Economic Review United States
  • Dr. Mouna Jameleddine
    Director, HTA Department, INEAS Tunisia
  • Dr. Aurelio Meija
    Director, IETS Colombia
  • Dr. Jo Carol Hiatt
    Vice President, Medical Device Consortium USA
  • Dr. Andres Pichon
    Executive Director, Institute for Clinical Effectiveness and Health Policy (IECS) Argentina
  • Dr. Meindert Boysen
    Deputy Chief Executive & Director of Centre for Health Technology Evaluation, National Institute for Health and Care Excellence UK
  • Dr. Claudia Wild
    Chief Executive, AIHTA GesmbH Austria
  • Mr. Parashar Patel
    SVP, Government Affairs & Market Access, VIEWRAY USA
  • Prof. Tracy Merlin
    Professor / Director, AHTA | Interim Head, School of Public Health, Adelaide Health Technology Assessment (AHTA), University of Adelaide Australia
  • Prof. Rabia Kahveci
    Senior Technical Advisor, SafeMed Ukraine
  • Mrs. Nuriya Musina
    Associate Professor, Center of Healthcare Quality Assessment and Control Russia
  • Dr. Iga Lipska
    Hospital Based HTA Project Leader, National Health Fund Poland
  • Ms. Maoling Wei
    Associate Professor of Experiments, The Center for Evidence-based Medicine and Clinical Epidemiology, West China Hospital, Sichuan University China
  • Dr. Armina Padmasawitri
    Lecturer, School of Pharmacy, Institut Teknologi Bandung Indonesia
  • Dr. Ryota Nakamura
    Associate Professor, Hitotsuhashi Institute for Advanced Study (HIAS) Health Japan
  • Prof. Dr. Judith Bosmans
    Professor, Vrije Universiteit Medical Center Netherlands
  • Dr. Massoud Toussi
    Senior Principal, Real World & Analytics Solutions, IQVIA France
  • Ms. Ivett Jakab
    President, EPF Youth Group and Syreon Research Institute
    Hungary
    Prof. Chiara de Waure
    Associate Professor, University Perugia Italy
  • Dr. Rosmin Esmail
    Provincial Trauma Epidemiologist, Alberta Health Services/ University of Calgary Canada
  • Mr. Ken Bond
    Director, HTA and External Relationships, Institute of Health Economics (IHE) Canada
  • Prof. Guy Maddern
    RP Jepson Professor of Surgery, University of Adelaide Australia
  • Dr. Dima Samaha
    Principal, Real World Solutions, IQVIA UK
  • Dr. Joice Valentim
    Health Systems Strategy Lead, HTA, Roche Switzerland
  • Ms. Ursula Giedion
    Coordinator, CRITERIA-IDB Switzerland

TECHNICAL OFFICER:

  • Dr. Saskia Knies Senior Advisor, National Health Care Institute
    Netherlands

HTAi COMMITTEES AND WORKING GROUPS

CHAIR:

  • Wija Oortwijn, President (The Netherlands)

MEMBERS:

  • Rabia Kahveci, Vice-President (Ukraine)
  • Americo Cicchetti, Treasurer (Italy)
  • Jo Carol Hiatt, Secretary (USA)

HTAi SECRETARIAT

  • Rob Abbott, HTAi Executive Director (Canada)
  • Tatiana Hagerty, Senior Coordinator, Governance and Executive Projects (Canada)

Terms of Reference

CHAIR:

  • Americo Cicchetti, Treasurer (Italy)

MEMBERS:

  • Marco Marchetti (Italy)
  • Franz Waibel (Switzerland)
  • Jo Carol Hiatt  (USA)
  • Wim Goettsch (The Netherlands)

HTAi SECRETARIAT

  • Rob Abbott, HTAi Executive Director (Canada)
  • Melissa Donecz, HTAi Accounting Manager (Canada)

Terms of Reference

CHAIR:

  • Iñaki Gutierrez-Ibarluzea (Spain)

MEMBERS:

  • Vacant
  • Vacant

HTAi SECRETARIAT SUPPORT

  • Tatiana Hagerty, Coordinator, Governance & Executive Projects (Canada)
  • Rob Abbott, Executive Director (Canada)

Terms of Reference

CHAIR:

  • Franz Waibel (Switzerland)

MEMBERS:

  • Marco Marchetti (Italy)
  • Jani Mueller (South Africa)
  • Neil Bertelsen (German)
  • VACANT
  • Parashar Patel (United States)
  • Anke-Peggy Holtorf (Switzerland)
  • Jeanette Kusel (United Kingdom)

HTAi SECRETARIAT SUPPORT:

  • Rob Abbott, HTAi Executive Director (Canada)

Terms of Reference

CHAIR:

  • Jani Mueller (South Africa)

MEMBERS:

  • Alric Rüther (Germany)
  • Americo Cicchetti (Italy)
  • Andre Pichon-Riviere (Argentina)
  • Elena Petelos (The Netherlands)
  • Gert Jan van der Wilt  (The Netherlands)
  • Wija Oortwijn (The Netherlands)
  • Yingyao Chen (China)
  • Maoling Wei (China)
  • Sharmila Alina de Sousa (Brazil)
  • Franz Waibel (Switzerland) 

HTAi SECRETARIAT SUPPORT:

  • Rob Abbott, HTAi Executive Director (Canada)
  • Antonio Migliore, HTAi Manager, Scientific Initiatives (Canada)

Terms of Reference

CHAIR:

  • Wim Goettsch (The Netherlands)

MEMBERS:

  • Clifford Goodman (USA)
  • Iñaki Gutierrez-Ibarluzea (Spain)
  • Keng Ho Pwee (Singapore)
  • Alric Rüther (Germany)
  • Tracy Merlin (Australia)
  • Ana Perez Galan (Uruguay)

HTAi SECRETARIAT SUPPORT:

  • Rob Abbott, HTAi Executive Director (Canada)
  • Denise Jarrett, HTAi Manager, Annual Meeting (UK)
  • Amren Thakur, HTAi Senior Coordinator, Scientific Initiatives (Canada)

Terms of Reference

CHAIR:

  • Alicia Granados (Spain)

MEMBERS:

  • Clifford Goodman (United States)
  • Wija Oortwijn (The Netherlands)
  • Adrian Griffin (United Kingdom)
  • Christopher Henshall (United Kingdom)
  • Jasmine Pwu (Taiwan)
  • Andres Pichon-Riviere (Argentina)
  • Dan Ollendorf (United States)
  • Suzanne McGurn (Canada)
  • Guy Maddern (Australia)
  • Manuel Antonio Espinoza (Chile)

HTAi SECRETARIAT SUPPORT:

  • Rob Abbott, HTAi Executive Director (Canada)
  • Alicia Powers, HTAi Manager, Events (Canada)

Terms of Reference

CHAIR:

  • Rabia Kahveci (Ukraine)

MEMBERS:

  • Rosmin Esmail, Disinvestment and Early Awareness, Co-Chair (Canada)
  • Nora Ibargoyen Roteta, Disinvestment and Early Awareness, Co-Chair (Spain)
  • Denny John, Early Career Network, Co-Chair
  • Maoling Wei, Early Career Network,Co-Chair (China)
  • Pietro Refolo, Ethics, Co-chair (Italy)
  • Bart Bloemen, Ethics, Co-chair (The Netherlands)
  • Jani Mueller, HTA in Developing Countries, Chair (South Africa)
  • Richard Charter, Medical Devices, Chair (Switzerland)
  • Anastasia Chalkidou, Medical Devices, Co-Chair (UK)
  • Rossella Di Bidino, Hospital-Based HTA, Co-chair (Italy)
  • Iga Lipska, Hospital-Based HTA, Co-chair (Poland)
  • Maarten Postma, Public Health, Chair (The Netherlands)
  • Ingrid Harboe, Information Retrieval Group, Chair (Norway)
  • Amanda Hodgson, Information Retrieval Group, Co-Chair (Canada)
  • Ann Single, Patient and Citizen Involvement, Chair (Australia)
  • Valentina Strammielllo, Patient and Citizen Involvement, Co-Chair (Brussels)
  • VACANT – Patient and Citizen Involvement, Vice-Chair
  • Massoud Toussi, Regulatory Interactions & Conditional Coverage, Chair (France)
  • Elena Petelos, Real World Evidence and Artificial Intelligence, Co-Chair (The Netherlands)
  • Dimitra Lingri, Real World Evidence and Artificial Intelligence, Co-Chair (Greece)

HTAi SECRETARIAT SUPPORT:

  • Rob Abbott, HTAi Executive Director (Canada)
  • Antonio Migliore, HTAi Manager, Scientific Initiatives (Canada)

CHAIR:

  • Dan Ollendorf (USA)

SCIENTIFIC SECRETARY:

  • Rebecca Trowman (Australia)

MEMBERS:

  • Andrew Mitchell (Australia)
  • Mohit Jain (UK) 
  • Wim Goettsch (Netherlands)
  • Iñaki Gutierrez Ibarluzea (Spain)
  • Wija Oortwijn (Netherlands)
  • Racho Strauven (Switzerland)

OBSERVERS:

  • Rob Abbott, HTAi Secretariat (Canada)
  • Ali Powers, Manager, Events (HTAi Secretariat, Canada)

Terms of Reference

CHAIR:

  • Guy Maddern (Australia)

SCIENTIFIC SECRETARY:

  • Linda Mundy (Australia)

MEMBERS:

  • Yan Ma (Viva) (Singapore)
  • Virginia Priest (New Zealand)
  • Parashar Patel (United States)
  • Sang-Soo(SS) Lee (Seoul, Korea)
  • Vanessa Xavier (Australia)
  • Izzuna Mudla Mohamed Ghazali (Kuala Lumpur, Malaysia)
  • Li-Ying Huang (Grace) (Taipei, Taiwan)
  • Julie Van Bavel (Australia)
  • Takashi Fakuda (Japan)
  • Hong Ju (Singapore)
  • Yingyao Chen (China)

HTAi SECRETARIAT:

  • Ali Powers, HTAi Manager, Events Canada)

Terms of Reference

CHAIR:

  • Manuel Antonio Espinoza

SCIENTIFIC SECRETARY:

  • Andres Pichon-Riviere (Scientific Secretary)
  • Gabriela Rodriguez (Administrative Contact)

MEMBERS:

  • Adriana Maria Robayo (Colombia)
  • Alicia Granados (Spain)
  • Dino Sepuilveda Viveros (Chile)
  • Fernanda Laranjeira (Brazil)
  • Hector Castro (United States)
  • Graciela Fernandez (Brazil)
  • Homero Monsanto (United States)
  • Vania Cristina Canuto Santos (Brazil)
  • William Dorling (United States)

HTAi SECRETARIAT:

  • Ali Powers, HTAi Manager, Events Canada)

Terms of Reference

CO-CHAIRS:

  • Prof. Dr. Gert van der Wilt
    Head of the HTA Unit, Radboud University Medical Centre
    Netherlands

  • Dr. W.G. Goettsch
    Special Advisor HTA, Zorginstituut Nederland and Utrecht University
    Netherlands

  • Ms. Ann Single
    Coordinator, Patient Voice Initiative | Chair, HTAi Patient and Citizen Involvement Interest Group
    Australia

MEMBERS:

  • Dr. Alric Rüther
    Head of International Affairs, Institute for Quality and Efficiency in Health Care (IQWiG) Germany
  • Dr. Izzuna Mudla Mohamed Ghazali
    Deputy Director, Ministry of Health Malaysia
  • Dr. Jon Campbell
    Sr Vice President, Health Economics, Institute for Clinical and Economic Review United States
  • Dr. Mouna Jameleddine
    Director, HTA Department, INEAS Tunisia
  • Dr. Aurelio Meija
    Director, IETS Colombia
  • Dr. Jo Carol Hiatt
    Vice President, Medical Device Consortium USA
  • Dr. Andres Pichon
    Executive Director, Institute for Clinical Effectiveness and Health Policy (IECS) Argentina
  • Dr. Meindert Boysen
    Deputy Chief Executive & Director of Centre for Health Technology Evaluation, National Institute for Health and Care Excellence UK
  • Dr. Claudia Wild
    Chief Executive, AIHTA GesmbH Austria
  • Mr. Parashar Patel
    SVP, Government Affairs & Market Access, VIEWRAY USA
  • Prof. Tracy Merlin
    Professor / Director, AHTA | Interim Head, School of Public Health, Adelaide Health Technology Assessment (AHTA), University of Adelaide Australia
  • Prof. Rabia Kahveci
    Senior Technical Advisor, SafeMed Ukraine
  • Mrs. Nuriya Musina
    Associate Professor, Center of Healthcare Quality Assessment and Control Russia
  • Dr. Iga Lipska
    Hospital Based HTA Project Leader, National Health Fund Poland
  • Ms. Maoling Wei
    Associate Professor of Experiments, The Center for Evidence-based Medicine and Clinical Epidemiology, West China Hospital, Sichuan University China
  • Dr. Armina Padmasawitri
    Lecturer, School of Pharmacy, Institut Teknologi Bandung Indonesia
  • Dr. Ryota Nakamura
    Associate Professor, Hitotsuhashi Institute for Advanced Study (HIAS) Health Japan
  • Prof. Dr. Judith Bosmans
    Professor, Vrije Universiteit Medical Center Netherlands
  • Dr. Massoud Toussi
    Senior Principal, Real World & Analytics Solutions, IQVIA France
  • Ms. Ivett Jakab
    President, EPF Youth Group and Syreon Research Institute
    Hungary
    Prof. Chiara de Waure
    Associate Professor, University Perugia Italy
  • Dr. Rosmin Esmail
    Provincial Trauma Epidemiologist, Alberta Health Services/ University of Calgary Canada
  • Mr. Ken Bond
    Director, HTA and External Relationships, Institute of Health Economics (IHE) Canada
  • Prof. Guy Maddern
    RP Jepson Professor of Surgery, University of Adelaide Australia
  • Dr. Dima Samaha
    Principal, Real World Solutions, IQVIA UK
  • Dr. Joice Valentim
    Health Systems Strategy Lead, HTA, Roche Switzerland
  • Ms. Ursula Giedion
    Coordinator, CRITERIA-IDB Switzerland

TECHNICAL OFFICER:

  • Dr. Saskia Knies Senior Advisor, National Health Care Institute
    Netherlands

HTAi Board Nominations open February 2023

HTAi Board Nominations open February 2023